Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an In vitro wound model

Infection and Immunity

Volumn 82, Issue 11, 2014, Pages 4718-4728

  DeLeon, Stephanie ^a   Clinton, Allie ^a   Fowler, Haley ^a   Everett, Jake ^a   Horswill, Alexander R ^b   Rumbaugh, Kendra P ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM CULTURE; COCULTURE; EXTRACELLULAR MATRIX; IN VITRO STUDY; MIXED INFECTION; MOUSE; NONHUMAN; ORGANISMAL INTERACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; WOUND INFECTION; DRUG EFFECTS; MICROBIOLOGICAL EXAMINATION; PHYSIOLOGY; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; COCULTURE TECHNIQUES; DRUG RESISTANCE, BACTERIAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84907961902     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02198-14     Document Type: Article

References (60)

1. Wolcott RD, Rhoads DD, Bennett ME, Wolcott BM, Gogokhia L, Costerton JW, Dowd SE. 2010. Chronic wounds and the medical biofilm paradigm. J. Wound Care 19:45-46, 48-50, 52-53. http://dx.doi.org/10.12968/jowc.2010.19.2.46966.
2. Cunningham AB. 2006. Biofilms: the hypertextbook. Montana State University, Bozeman, MT.
3. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS. 2008. Biofilms in chronic wounds. Wound Repair Regen. 16:37-44. http://dx.doi.org/10.1111/j.1524-475X.2007.00321.x.
4. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, Wolcott RD. 2008. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing.BMCMicrobiol. 8:43. http://dx.doi.org/10.1186/1471-2180-8-43.
5. Singh VA, Barbul A. 2008. Bacterial biofilms in wounds. Wound Repair Regen. 16:1. http://dx.doi.org/10.1111/j.1524-475X.2007.00349.x.
6. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, Hoiby N, Givskov M. 2008. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen. 16:2-10. http://dx.doi.org/10.1111/j.1524-475X.2007.00283.x.
7. Trivedi U, Parameswaran S, Armstrong A, Burgueno-Vega D, Griswold J, Dissanaike S, Rumbaugh KP. 2014. Prevalence of multiple antibiotic resistant infections in diabetic versus nondiabetic wounds. J. Pathog. 2014:173053. http://dx.doi.org/10.1155/2014/173053.
8. Bessa LJ, Fazii P, Di Giulio M, Cellini L. 24 February 2013. Bacterial isolates from infected wounds and their antibiotic susceptibility pattern: some remarks about wound infection. Int. Wound J. http://dx.doi.org/10.1111/iwj.12049.
9. Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA. 2006. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int. Wound J. 3:225-231. http://dx.doi.org/10.1111/j.1742-481X.2006.00159.x.
10. Körber A, Schmid EN, Buer J, Klode J, Schadendorf D, Dissemond J. 2010. Bacterial colonization of chronic leg ulcers: current results compared with data 5 years ago in a specialized dermatology department. J. Eur. Acad. Dermatol. Venereol. 24:1017-1025. http://dx.doi.org/10.1111/j.1468-3083.2010.03570.x.
11. Fazli M, Bjarnsholt T, Kirketerp-Moller K, Jorgensen B, Andersen AS, Krogfelt KA, Givskov M, Tolker-Nielsen T. 2009. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J. Clin. Microbiol. 47:4084-4089. http://dx.doi.org/10.1128/JCM.01395-09.
12. Pastar I, Nusbaum AG, Gil J, Patel SB, Chen J, Valdes J, Stojadinovic O, Plano LR, Tomic-Canic M, Davis SC. 2013. Interactions of methicillin resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection. PLoS One 8:e56846. http://dx.doi.org/10.1371/journal.pone.0056846.
13. Rosenbluth DB, Wilson K, Ferkol T, Schuster DP. 2004. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest 126:412-419. http://dx.doi.org/10.1378/chest.126.2.412.
14. Hendricks KJ, Burd TA, Anglen JO, Simpson AW, Christensen GD, Gainor BJ. 2001. Synergy between Staphylococcus aureus and Pseudomonas aeruginosa in a rat model of complex orthopaedic wounds. J. Bone Joint Surg. Am. 83-A:855-861.
15. Ramakant P, Verma AK, Misra R, Prasad KN, Chand G, Mishra A, Agarwal G, Agarwal A, Mishra SK. 2011. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia 54:58-64. http://dx.doi.org/10.1007/s00125-010-1893-7.
16. Bansal E, Garg A, Bhatia S, Attri AK, Chander J. 2008. Spectrum of microbial flora in diabetic foot ulcers. Indian J. Pathol. Microbiol. 51:204-208. http://dx.doi.org/10.4103/0377-4929.41685.
17. Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. 2005. Bacteriological study of diabetic foot infections. J. Diabetes Complications 19:138-141. http://dx.doi.org/10.1016/j.jdiacomp.2004.06.001.
18. Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torne A, Witte W, Friedrich AW. 2010. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill. 15:19688. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19688.
19. Flamm RK, Weaver MK, Thornsberry C, Jones ME, Karlowsky JA, Sahm DF. 2004. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob. Agents Chemother. 48:2431-2436. http://dx.doi.org/10.1128/AAC.48.7.2431-2436.2004.
20. Gefen O, Balaban NQ. 2009. The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol. Rev. 33:704-717. http://dx.doi.org/10.1111/j.1574-6976.2008.00156.x.
21. Palmer KL, Aye LM, Whiteley M. 2007. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189:8079-8087. http://dx.doi.org/10.1128/JB.01138-07.
22. Palmer KL, Mashburn LM, Singh PK, Whiteley M. 2005. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 187:5267-5277. http://dx.doi.org/10.1128/JB.187.15.5267-5277.2005.
23. Mansito TB, Falcon MA, Moreno J, Carnicero A, Gutierrez-Navarro AM. 1987. Effects of staphylolytic enzymes from Pseudomonas aeruginosa on the growth and ultrastructure of Staphylococcus aureus. Microbios 49:55-64.
24. Hoffman LR, Deziel E, D'Argenio DA, Lepine F, Emerson J, McNamara S, Gibson RL, Ramsey BW, Miller SI. 2006. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 103:19890-19895. http://dx.doi.org/10.1073/pnas.0606756104.
25. Qin Z, Yang L, Qu D, Molin S, Tolker-Nielsen T. 2009. Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiology 155:2148-2156. http://dx.doi.org/10.1099/mic.0.028001-0.
26. Dietrich LE, Price-Whelan A, Petersen A, Whiteley M, Newman DK. 2006. The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of Pseudomonas aeruginosa. Mol. Microbiol. 61:1308-1321. http://dx.doi.org/10.1111/j.1365-2958.2006.05306.x.
27. Moore JE, Shaw A, Millar BC, Downey DG, Murphy PG, Elborn JS. 2005. Microbial ecology of the cystic fibrosis lung: does microflora type influence microbial loading? Br. J. Biomed. Sci. 62:175-178.
28. FitzSimmons SC. 1993. The changing epidemiology of cystic fibrosis. J. Pediatr. 122:1-9. http://dx.doi.org/10.1016/S0022-3476(05)83478-X.
29. Holloway BW, Krishnapillai V, Morgan AF. 1979. Chromosomal genetics of Pseudomonas. Microbiol. Rev. 43:73-102.
30. Li LL, Malone JE, Iglewski BH. 2007. Regulation of the Pseudomonas aeruginosa quorum-sensing regulator VqsR. J. Bacteriol. 189:4367-4374. http://dx.doi.org/10.1128/JB.00007-07.
31. Schaber JA, Triffo WJ, Suh SJ, Oliver JW, Hastert MC, Griswold JA, Auer M, Hamood AN, Rumbaugh KP. 2007. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect. Immun. 75:3715-3721. http://dx.doi.org/10.1128/IAI.00586-07.
32. Watters C, Everett JA, Haley C, Clinton A, Rumbaugh KP. 2014. Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms. Infect. Immun. 82:92-100. http://dx.doi.org/10.1128/IAI.00651-13.
33. Boles BR, Thoendel M, Roth AJ, Horswill AR. 2010. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:e10146. http://dx.doi.org/10.1371/journal.pone.0010146.
34. Lauderdale KJ, Boles BR, Cheung AL, Horswill AR. 2009. Interconnections between sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect. Immun. 77:1623-1635. http://dx.doi.org/10.1128/IAI.01036-08.
35. Sun Y, Dowd SE, Smith E, Rhoads DD, Wolcott RD. 2008. In vitro multispecies Lubbock chronic wound biofilm model. Wound Repair Regen. 16:805-813. http://dx.doi.org/10.1111/j.1524-475X.2008.00434.x.
36. Watters C, DeLeon K, Trivedi U, Griswold JA, Lyte M, Hampel KJ, Wargo MJ, Rumbaugh KP. 2013. Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. Med. Microbiol. Immunol. 202:131-141. http://dx.doi.org/10.1007/s00430-012-0277-7.
37. Dalton T, Dowd SE, Wolcott RD, Sun Y, Watters C, Griswold JA, Rumbaugh KP. 2011. An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS One 6:e27317. http://dx.doi.org/10.1371/journal.pone.0027317.
38. Sun Y, Smith E, Wolcott R, Dowd SE. 2009. Propagation of anaerobic bacteria within an aerobic multi-species chronic wound biofilm model. J. Wound Care 18:426-431. http://dx.doi.org/10.12968/jowc.2009.18.10.44604.
39. Dowd SE, Sun Y, Smith E, Kennedy JP, Jones CE, Wolcott R. 2009. Effects of biofilm treatments on the multi-species Lubbock Chronic Wound Biofilm model. J. Wound Care 18:508, 510-512. http://dx.doi.org/10.12968/jowc.2009.18.12.45608.
40. Zajdel M, Wagrzynowicz Z, Jeljaszewicz J. 1975. Action of staphylothrombin on bovine fibrinogen. Thromb. Res. 6:501-510. http://dx.doi.org/10.1016/0049-3848(75)90062-6.
41. Kirketerp-Moller K, Jensen PO, Fazli M, Madsen KG, Pedersen J, Moser C, Tolker-Nielsen T, Hoiby N, Givskov M, Bjarnsholt T. 2008. Distribution, organization, and ecology of bacteria in chronic wounds. J. Clin. Microbiol. 46:2717-2722. http://dx.doi.org/10.1128/JCM.00501-08.
42. Mendes JJ, Neves J. 2012. Diabetic foot infections: current diagnosis and treatment. J. Diabetic Foot Complications 4:26-45.
43. Burmolle M, Webb JS, Rao D, Hansen LH, Sorensen SJ, Kjelleberg S. 2006. Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl. Environ. Microbiol. 72:3916-3923. http://dx.doi.org/10.1128/AEM.03022-05.
44. Harriott MM, Noverr MC. 2009. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob. Agents Chemother. 53:3914-3922. http://dx.doi.org/10.1128/AAC.00657-09.
45. Poole K. 2005. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:479-487. http://dx.doi.org/10.1128/AAC.49.2.479-487.2005.
46. Connell JL, Ritschdorff ET, Whiteley M, Shear JB. 2013. 3D printing of microscopic bacterial communities. Proc. Natl. Acad. Sci. U. S. A. 110:18380-18385. http://dx.doi.org/10.1073/pnas.1309729110.
47. Li XZ, Livermore DM, Nikaido H. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob. Agents Chemother. 38:1732-1741. http://dx.doi.org/10.1128/AAC.38.8.1732.
48. Jeannot K, Sobel ML, El Garch F, Poole K, Plesiat P. 2005. Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drugribosome interaction. J. Bacteriol. 187:5341-5346. http://dx.doi.org/10.1128/JB.187.15.5341-5346.2005.
49. Schmitz FJ, Krey A, Sadurski R, Verhoef J, Milatovic D, Fluit AC. 2001. Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates. J. Antimicrob. Chemother. 47:239-240. http://dx.doi.org/10.1093/jac/47.2.239.
50. Hope R, Warner M, Mushtaq S, Ward ME, Parsons T, Livermore DM. 2005. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines. J. Antimicrob. Chemother. 56:1042-1046. http://dx.doi.org/10.1093/jac/dki386.
51. Alhede M, Kragh KN, Qvortrup K, Allesen-Holm M, van Gennip M, Christensen LD, Jensen PO, Nielsen AK, Parsek M, Wozniak D, Molin S, Tolker-Nielsen T, Hoiby N, Givskov M, Bjarnsholt T. 2011. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PLoS One 6:e27943. http://dx.doi.org/10.1371/journal.pone.0027943.
52. O'Gara JP. 2007. ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol. Lett. 270:179-188. http://dx.doi.org/10.1111/j.1574-6968.2007.00688.x.
53. Bragonzi A, Worlitzsch D, Pier GB, Timpert P, Ulrich M, Hentzer M, Andersen JB, Givskov M, Conese M, Doring G. 2005. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J. Infect. Dis. 192:410-419. http://dx.doi.org/10.1086/431516.
54. Shahidi A, Ellner PD. 1969. Effect of mixed cultures on antibiotic susceptibility testing. Appl. Microbiol. 18:766-770.
55. Wolcott RD, Cox SB, Dowd SE. 2010. Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics. J. Wound Care 19:272-278, 280-281.
56. Vercellotti GM, McCarthy JB, Lindholm P, Peterson PK, Jacob HS, Furcht LT. 1985. Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am. J. Pathol. 120:13-21.
57. Heilmann C. 2011. Adhesion mechanisms of staphylococci. Adv. Exp. Med. Biol. 715:105-123. http://dx.doi.org/10.1007/978-94-007-0940-9_7.
58. Song J, Choi B, Jin EJ, Yoon Y, Choi KH. 2012. Curcumin suppresses Streptococcus mutans adherence to human tooth surfaces and extracellular matrix proteins. Eur. J. Clin. Microbiol. Infect. Dis. 31:1347-1352. http://dx.doi.org/10.1007/s10096-011-1448-y.
59. Srinivasan A, Uppuluri P, Lopez-Ribot J, Ramasubramanian AK. 2011. Development of a high-throughput Candida albicans biofilm chip. PLoS One 6:e19036. http://dx.doi.org/10.1371/journal.pone.0019036.
60. Tseng BS, Zhang W, Harrison JJ, Quach TP, Song JL, Penterman J, Singh PK, Chopp DL, Packman AI, Parsek MR. 2013. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ. Microbiol. 15:2865-2878. http://dx.doi.org/10.1111/1462-2920.12155.